CSIMarket
 
Biomarin Pharmaceutical Inc  (NASDAQ: BMRN)
 

Biomarin Pharmaceutical Inc's Customers Performance

BMRN



 
BMRN's Source of Revenues During the corresponding time, Biomarin Pharmaceutical Inc recorded a revenue increase by 19.91 % year on year, sequentially revenue grew by 29.17 %. While revenue at the Biomarin Pharmaceutical Inc's corporate clients

List of BMRN Customers




for the same period Biomarin Pharmaceutical Inc recorded revenue increase by 19.91 % year on year, sequentially revenue grew by 29.17 %.

List of BMRN Customers

Biomarin Pharmaceutical Inc's Business Units
Product    176.26 % of total Revenue
Royalty and Other    1.16 % of total Revenue
Reportable    177.42 % of total Revenue
VOXZOGO    47.73 % of total Revenue
VIMIZIM    40.88 % of total Revenue
NAGLAZYME    26.81 % of total Revenue
PALYNZIQ    22.71 % of total Revenue
Galafold    10.68 % of total Revenue
BRINEURA    9.95 % of total Revenue
ALDURAZYME    8.11 % of total Revenue
Pombiliti + Opfolda    3.06 % of total Revenue
KUVAN    4.88 % of total Revenue
ROCTAVIAN    1.45 % of total Revenue
Products Excluding Aldurazyme    168.15 % of total Revenue






Biomarin Pharmaceutical Inc's Comment on Sales, Marketing and Customers
















BMRN's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Biomarin Pharmaceutical Inc 12,587.85 3,242.32 268.74 3,221
SUBTOTAL 0.00 0.00 0.00 -

Sources: Biomarin Pharmaceutical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Biomarin Pharmaceutical Inc’s corporate clients.
For your research, we’ve provided 9 tables on Biomarin Pharmaceutical Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.